These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18704986)

  • 1. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation.
    Choi M; Sun CL; Kurian S; Carter A; Francisco L; Forman SJ; Bhatia S
    Cancer; 2008 Oct; 113(7):1580-7. PubMed ID: 18704986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.
    Campbell S; Sun CL; Kurian S; Francisco L; Carter A; Kulkarni S; Parker P; Karanes C; Forman SJ; Bhatia S
    Cancer; 2009 Sep; 115(18):4127-35. PubMed ID: 19536905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
    Wu NL; Hingorani S; Cushing-Haugen KL; Lee SJ; Chow EJ
    Transplant Cell Ther; 2021 May; 27(5):434.e1-434.e6. PubMed ID: 33775588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.
    Buchbinder D; Nugent DJ; Brazauskas R; Wang Z; Aljurf MD; Cairo MS; Chow R; Duncan C; Eldjerou LK; Gupta V; Hale GA; Halter J; Hayes-Lattin BM; Hsu JW; Jacobsohn DA; Kamble RT; Kasow KA; Lazarus HM; Mehta P; Myers KC; Parsons SK; Passweg JR; Pidala J; Reddy V; Sales-Bonfim CM; Savani BN; Seber A; Sorror ML; Steinberg A; Wood WA; Wall DA; Winiarski JH; Yu LC; Majhail NS
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1776-84. PubMed ID: 22863842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-term Transplant Survivors.
    Li A; Gupta R; Amos CI; Davis C; Pao E; Lee SJ; Hingorani SR
    Transplant Cell Ther; 2021 Oct; 27(10):864.e1-864.e5. PubMed ID: 34217847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
    Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
    JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease after hematopoietic cell transplantation: frequency, risk factors, and outcomes.
    Saddadi F; Hakemi M; Najafi I; Moghadam K; Ghavamzadeh A; Jahani M; Ganji M; Amini M; Soleimanian T
    Transplant Proc; 2009 Sep; 41(7):2895-7. PubMed ID: 19765466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.
    Majhail NS; Brunstein CG; McAvoy S; DeFor TE; Al-Hazzouri A; Setubal D; Arora M; Le CT; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):985-992. PubMed ID: 18721761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.
    Khera N; Storer B; Flowers ME; Carpenter PA; Inamoto Y; Sandmaier BM; Martin PJ; Lee SJ
    J Clin Oncol; 2012 Jan; 30(1):71-7. PubMed ID: 22147737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.
    Bhatia S; Robison LL; Francisco L; Carter A; Liu Y; Grant M; Baker KS; Fung H; Gurney JG; McGlave PB; Nademanee A; Ramsay NK; Stein A; Weisdorf DJ; Forman SJ
    Blood; 2005 Jun; 105(11):4215-22. PubMed ID: 15701723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.
    Sun CL; Kersey JH; Francisco L; Armenian SH; Baker KS; Weisdorf DJ; Forman SJ; Bhatia S
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1073-80. PubMed ID: 23583827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.
    Atsuta Y; Hirakawa A; Nakasone H; Kurosawa S; Oshima K; Sakai R; Ohashi K; Takahashi S; Mori T; Ozawa Y; Fukuda T; Kanamori H; Morishima Y; Kato K; Yabe H; Sakamaki H; Taniguchi S; Yamashita T;
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1702-1709. PubMed ID: 27246369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.
    Goldman JM; Majhail NS; Klein JP; Wang Z; Sobocinski KA; Arora M; Horowitz MM; Rizzo JD
    J Clin Oncol; 2010 Apr; 28(11):1888-95. PubMed ID: 20212247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients.
    Montefusco V; Mussetti A; Rezzonico F; Maura F; Pennisi M; de Philippis C; Capecchi M; Corradini P
    Bone Marrow Transplant; 2017 Dec; 52(12):1602-1608. PubMed ID: 28892086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Chang EK; Chanson D; Teh JB; Iukuridze A; Peng K; Forman SJ; Nakamura R; Wong FL; Cai L; Armenian SH
    J Clin Oncol; 2021 Mar; 39(8):902-910. PubMed ID: 33417479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation.
    Sakellari I; Barbouti A; Bamichas G; Mallouri D; Kaloyannidis P; Fragidis S; Batsis I; Apostolou C; Karpouza A; Yannaki E; Smias C; Sombolos K; Anagnostopoulos A
    Bone Marrow Transplant; 2013 Oct; 48(10):1329-34. PubMed ID: 23584436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.